Chloride Channel Agonists

Name
Chloride Channel Agonists
Accession Number
DBCAT001249
Description

A class of drugs that stimulate chloride ion influx through cell membrane channels.

Drugs
DrugDrug Description
LubiprostoneA prostaglandin derivative used to treat constipation caused by irritable bowel syndrome and opioid-use.
IvacaftorA cystic fibrosis transmembrane conductance regulator (CFTR) potentiator used alone or in combination products to treat cystic fibrosis in patients who have specific genetic mutations that are responsive to the medication.
BamocaftorBamocaftor (VX-659) is under investigation in clinical trial NCT03224351 (A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis).
Drugs & Drug Targets
DrugTargetType
LubiprostoneChloride channel protein 2target
LubiprostoneCarbonyl reductase [NADPH] 1enzyme
IvacaftorCystic fibrosis transmembrane conductance regulatortarget
IvacaftorCytochrome P450 3A4enzyme
IvacaftorSerum albumincarrier
IvacaftorAlpha-1-acid glycoprotein 1carrier
IvacaftorP-glycoprotein 1transporter
IvacaftorCytochrome P450 3A5enzyme
IvacaftorCytochrome P450 2C9enzyme